Ispire Technology Inc. (NASDAQ: ISPR) reported its first quarter financial results on Tuesday, revealing a 59.1% year-over-year increase in revenue to $42.9 million in the three months ended Sept. 30, 2023.
MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) reported its financial results for the three months ended September 30, 2023, with a revenue of C$8.5 million. This reflects a decrease of around C$1 million sequentially but an increase of C$1.3 million over the year.
Clinical-stage psychedelics company atai Life Sciences (NASDAQ: ATAI) reported its financial results and corporate updates for the third quarter ended September 30, 2023.
In numbers: